Vuk Cerovic

Vuk Cerovic

Auto-generated profile, based on publicly available information

Vuk Cerovic

Institute of Molecular Medicine, RWTH Aachen University, Aachen, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2023 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PDF file
OPOliver Pabst
Oliver Pabst
MHMathias W. Hornef
Mathias W. Hornef
FSFrank Schaap
Frank Schaap
VCVuk Cerovic
Vuk Cerovic
TCThomas Clavel
Thomas Clavel
Tony BrunsTony Bruns
Tony Bruns

1 January 2022 in Mucosal Immunology
Verified
Journal Article
Closed access
PDF file
CLCécilia Luciani
Cécilia Luciani
FHFabian Tobias Hager
Fabian Tobias Hager
VCVuk Cerovic
Vuk Cerovic
HLHugues Lelouard
Hugues Lelouard

6 September 2024 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
VCVuk Cerovic
Vuk Cerovic
OPOliver Pabst
Oliver Pabst
AMAllan McI Mowat
Allan McI Mowat

28 January 2026 in Nature
Verified
Journal Article
Open access
PDF file
SSSebastiaan De Schepper
Sebastiaan De Schepper
VKViktoras Konstantellos
Viktoras Konstantellos
JCJames A. Conway
James A. Conway
DSDimitra Sokolova
Dimitra Sokolova
LZLudovica Zaccagnini
Ludovica Zaccagnini
TBTim Bartels
Tim Bartels
Emerging evidence suggests that Parkinson’s disease (PD) may have its origin in the enteric nervous system (ENS), from where α-synuclein (αS) pathology spreads to the brain1,2,3,4. Decades before the onset of motor symptoms, patients with PD suffer from constipation and present with circulating T cells responsive to αS, suggesting that peripheral immune responses initiated in the ENS may be involved in the early stages of PD1,5,6,7. However, cellular mechanisms that trigger αS pathology in the ENS and its spread along the gut–brain axis remain elusive. Here we demonstrate that muscularis macrophages (ME-Macs), housekeepers of ENS integrity and intestinal homeostasis, modulate αS pathology and neurodegeneration in models of PD8,9. ME-Macs contain misfolded αS, adopt a signature reflecting endolysosomal dysfunction and modulate the expansion of T cells that travel from the ENS to the brain through the dura mater as αS pathology progresses. Directed ME-Mac depletion leads to reduced αS pathology in the ENS and central nervous system, prevents T cell expansion and mitigates neurodegeneration and motor dysfunction, suggesting a role for ME-Macs as early cellular initiators of αS pathology along the gut–brain axis. Understanding these mechanisms could pave the way for early-stage biomarkers in PD.

27 January 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JGJoël Guillaume
Joël Guillaume
ALAndrea Leufgen
Andrea Leufgen
FHFabian T. Hager
Fabian T. Hager
OPOliver Pabst
Oliver Pabst
VCVuk Cerovic
Vuk Cerovic
Macrophages are traditionally considered antigen-presenting cells. However, their ability to present antigen and the factors regulating macrophage MHCII expression are poorly understood. Here, we demonstrate that MHCII expression on murine intestinal macrophages is differentially controlled by their residence in the small intestine (SI) or the colon, their ontogeny and the gut microbiota. Monocyte-derived macrophages are uniformly MHCIIhi, independently of the tissue of residence, microbial status or the age of the mouse, suggesting a common monocyte differentiation pathway. In contrast, MHCII expression on long-lived, prenatally-derived Tim4+ macrophages is low after birth but significantly increases at weaning in both SI and colon. Furthermore, MHCII expression on colonic Tim4+, but not monocyte-derived macrophages, is dependent on recognition of microbial stimuli, as MHCII expression is significantly downregulated in germ-free, antibiotic-treated and MyD88 deficient mice. To address the function of MHCII presentation by intestinal macrophages we established two models of macrophage-specific MHCII deficiency. We observed a significant reduction in the overall frequency and number of tissue-resident, but not newly arrived, SI CD4+ T cells in the absence of macrophage-expressed MHCII. Our data suggest that macrophage MHCII provides signals regulating gut CD4+ T cell maintenance with different requirements in the SI and colon.

24 November 2023 in Science Immunology
Verified
Journal Article
Closed access
AKAnne Kaminski
Anne Kaminski
FHFabian Tobias Hager
Fabian Tobias Hager
LKLydia Kopplin
Lydia Kopplin
FTFabio Ticconi
Fabio Ticconi
ALAndrea Leufgen
Andrea Leufgen
MUMilas Ugur
Milas Ugur
Regulatory T cells (T regs ) are present in lymphoid and nonlymphoid tissues where they restrict immune activation, prevent autoimmunity, and regulate inflammation. T regs in nonlymphoid tissues are typically resident, whereas those in lymph nodes (LNs) are considered to recirculate. However, T regs in LNs are not a homogenous population, and circulation kinetics of different T reg subsets are poorly characterized. Furthermore, whether T regs can acquire memory T cell properties and persist for extended periods after their activation in LNs is unclear. Here, we used in situ labeling with a stabilized photoconvertible protein to uncover turnover rates of T regs in LNs in vivo. We found that, whereas most T regs in LNs recirculate, 10 to 20% are memory-like resident cells that remain in their respective LNs for weeks to months. Single-cell RNA sequencing revealed that LN-resident cells are a functionally and ontogenetically heterogeneous population and share the same core residency gene signature with conventional CD4 + and CD8 + T cells. Resident cells in LNs did not actively proliferate and did not require continuous T cell receptor (TCR) signaling for their residency. However, resident and circulating T regs had distinct TCR repertoires, and each LN contained exclusive clonal subpopulations of resident T regs . Our results demonstrate that, similar to conventional T cells, T regs can form resident memory-like populations in LNs after adaptive immune responses. Specific and local suppression of immune responses by resident T regs in draining LNs might provide previously unidentified therapeutic opportunities for the treatment of local chronic inflammatory conditions.